Skip to main content
Clinical Trials/NCT02756000
NCT02756000
Completed
Not Applicable

Appropriate Timing of Complete Revascularization for Multivessel Coronary Artery Disease After Culprit Only Primary Percutaneous Coronary Intervention (PCI) for ST Elevation Myocardial Infarction

Clinical Hospital Center Zemun4 sites in 1 country120 target enrollmentJanuary 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Myocardial Infarction
Sponsor
Clinical Hospital Center Zemun
Enrollment
120
Locations
4
Primary Endpoint
major adverse cardio-cerebral events
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The study will compare clinical outcomes between complete revascularization during hospitalization for ST elevation myocardial infarction (STEMI) and intervention after 30 days and intervention based on outpatient non-invasive ischemia testing in patients with multivessel coronary artery disease (MVD) presenting with first ever ST elevation myocardial infarction.

Detailed Description

This study is prospective, randomized, multicentre, open label study in patients with ST elevation myocardial infarction (STEMI) with multivessel coronary artery disease (MVD) defined as \>70% stenosis in a non-culprit vessel, initially treated with culprit only primary PCI. The patients will be enrolled in four high volume PCI centers after successful culprit only primary PCI and then randomly assigned to one of three treatment arms:1. complete revascularization of all non-culprit significant lesions in a single session during initial hospitalization; 2. same revascularization in a single session after 30 days; 3.revascularization or it's deferral based on ischemia testing using Dobutamin stress echocardiography. The study will explore differences in occurrence of major adverse cardio-cerebral events (cardiac death, repeated myocardial infarction, cerebrovascular accident and repeated revascularization) and complications of interventions during 12 months follow-up.

Registry
clinicaltrials.gov
Start Date
January 2016
End Date
November 2018
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Clinical Hospital Center Zemun
Responsible Party
Principal Investigator
Principal Investigator

Ivan Ilic

Head of interventional cardiology diagnostics

Clinical Hospital Center Zemun

Eligibility Criteria

Inclusion Criteria

  • Clinical and electrocardiographic signs of first ever ST elevation myocardial infarction (chest pain lasting less than 12 hours with persistent ST elevation of ≥ 1mm in two contiguous leads on ECG recording)
  • Multivessel coronary artery disease (MVD) on initial coronary angiogram, defined as visually assessed stenosis of more than 70% of any of the non-culprit vessels
  • Treated with primary PCI of infarct related artery (IRA) only.

Exclusion Criteria

  • Hemodynamically unstable patients defined as presence of cardiogenic shock, intraaortic balloon pump (IABP) implantation and mechanical ventilation prior, during and after primary PCI;
  • Presence of significant valvular disease;
  • Decision that patient needs to be treated with coronary artery bypass graft (CABG) and/or valvular replacement or reconstruction surgery after initial culprit only PCI;
  • Myocardial infarction is caused by stent thrombosis:
  • Chronic total occlusion of any of the coronary arteries on initial angiogram;
  • Previously treated by CABG surgery;
  • Estimated life expectancy less than one year.

Outcomes

Primary Outcomes

major adverse cardio-cerebral events

Time Frame: one year

cardiac death, repeated myocardial infarction, cerebrovascular accident and repeated revascularization

Secondary Outcomes

  • cardiac death(one year)
  • complications of percutaneous coronary intervention(one year)
  • hospitalization for heart failure(one year)
  • repeated myocardial infarction(one year)
  • stent thrombosis(two years)

Study Sites (4)

Loading locations...

Similar Trials